V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250008103 | 250011682 | 1.74 | 73 | Disease modification (D) | 2018-11-09 | 2018-11-09 | Azacitidine | null | null | 250014781 | AZACITIDINE |
| 250008104 | 250005577 | 1.63 | 73.8 | Palliative (P) | 2018-01-17 | 2018-01-18 | Trial Unspecified | 02 | N | 250014846 | DOXORUBICIN + OLARATUMAB |
| 250008105 | 250005577 | 1.84 | 0 | Disease modification (D) | 2017-09-08 | 2017-09-13 | CHOP R | N | N | 250014846 | VINORELBINE |
| 250008106 | 250005578 | null | 76.6 | Curative (C) | 2017-02-03 | 2017-02-03 | Trial Unspecified | null | N | 250014883 | VINORELBINE |
| 250008107 | 250005578 | 1.86 | null | Disease modification (D) | 2017-02-02 | 2017-02-12 | Gemcitabine weekly | 02 | N | 250014883 | CHLORAMBUCIL |
| 250008108 | 250005579 | 0 | 61.3 | Palliative (P) | 2015-10-13 | 2015-10-16 | CAPECITABINE + OXALIPLATIN | 2 | N | 250014959 | TRIAL |
| 250008109 | 250005580 | 1.7 | 63.4 | Curative (C) | null | 2017-05-31 | CARBOPLATIN + GEMCITABINE | 2 | N | 250014977 | CYTARABINE |
| 250008110 | 250009920 | 1.75 | 130 | Disease modification (D) | 2016-07-30 | 2016-07-30 | Carboplatin + Paclitaxel (3 weekly) | Y | N | 250015001 | IPM |
| 250008111 | 250005581 | 1.62 | 121.2 | Disease modification (D) | 2018-04-07 | 2018-04-07 | Pemetrexed | N | null | 250015045 | TRIAL |
| 250008112 | 250009921 | 1.64 | 96 | Disease modification (D) | 2015-08-05 | 2015-08-12 | RUXOLITINIB | 2 | N | 250015072 | RUXOLITINIB |
| 250008113 | 250005582 | 0 | 91.6 | Palliative (P) | 2017-07-07 | 2017-07-07 | Ipilimumab | N | N | 250015099 | IPM |
| 250008114 | 250005583 | null | 60.9 | Palliative (P) | 2017-01-15 | 2017-01-15 | Trial Unspecified | N | N | 250015161 | SORAFENIB |
| 250008115 | 250009922 | 1.78 | -1 | Adjuvant (A) | 2017-01-28 | 2017-02-11 | DA 3 + 10 | N | N | 250015163 | DOCETAXEL |
| 250008116 | 250009922 | 1.53 | 61.8 | Palliative (P) | 2017-12-15 | 2017-12-28 | MYELOMA XI TRIAL | N | N | 250015163 | AZACITIDINE |
| 250008117 | 250005584 | 1.9 | 59 | null | 2015-12-16 | 2015-12-16 | Vinorelbine (oral) | 01 | N | 250015288 | IMATINIB |
| 250008118 | 250005584 | 0 | 0 | Neo-adjuvant (N) | 2016-07-23 | 2016-07-23 | CARBOPLATIN + VINORELBINE | N | N | 250015288 | CARBOPLATIN |
| 250008119 | 250005584 | null | 57.5 | Adjuvant (A) | 2018-05-24 | 2018-05-24 | GemCarbo Days 1+8 | N | N | 250015288 | IPM |
| 250008120 | 250005585 | null | 47.3 | Palliative (P) | 2018-02-24 | 2018-03-11 | Cisplatin + Paclitaxel | N | N | 250015447 | PEMETREXED |
| 250008121 | 250005586 | null | null | Disease modification (D) | 2017-08-10 | 2017-08-30 | MESO-02 TRIAL | N | N | 250015501 | TRIAL |
| 250008122 | 250005586 | 1.73 | 75 | Neo-adjuvant (N) | 2018-07-30 | 2018-07-31 | IPM | 01 | N | 250015501 | VINORELBINE |
| 250008123 | 250005586 | 1.63 | 56 | Adjuvant (A) | 2013-05-17 | 2014-11-25 | Pemetrexed | N | N | 250015501 | PAZOPANIB |
| 250008124 | 250012419 | null | null | Adjuvant (A) | 2018-04-23 | 2018-04-23 | Trial Unspecified | 02 | null | 250015579 | TRIAL |
| 250008125 | 250012419 | 0 | 95.4 | Disease modification (D) | 2017-04-05 | 2017-04-05 | Cisplatin | N | N | 250015579 | CHLORAMBUCIL |
| 250008126 | 250005587 | 1.73 | 64 | Curative (C) | 2017-11-23 | 2017-11-23 | DA | 02 | N | 250015687 | CARBOPLATIN |
| 250008127 | 250005588 | null | 60 | Palliative (P) | 2016-01-28 | 2016-01-28 | CARBOPLATIN | Y | N | 250015721 | GEMCARBO |
| 250008128 | 250005589 | 1.68 | 84.8 | Adjuvant (A) | 2018-06-22 | 2018-06-22 | Cisplatin | 2 | N | 250015860 | RUXOLITINIB |
| 250008129 | 250005590 | 1.55 | 67.1 | Neo-adjuvant (N) | 2017-08-13 | 2017-08-13 | CISPLATIN + GEMCITABINE | null | N | 250015873 | IMATINIB |
| 250008130 | 250005591 | 1.74 | 102 | Palliative (P) | 2016-12-07 | 2016-12-07 | Trial Unspecified | N | N | 250015897 | FLAG + IDARUBICIN |
| 250008131 | 250005591 | 1.76 | 73.8 | Palliative (P) | 2016-06-27 | 2016-06-27 | Pemetrexed | 02 | N | 250015897 | TRIAL |
| 250008132 | 250005592 | 1.75 | null | Palliative (P) | 2018-03-31 | 2018-04-21 | Pemetrexed | Y | N | 250015943 | PAZOPANIB |
| 250008133 | 250009926 | 1.66 | 82 | Disease modification (D) | 2017-08-11 | 2017-09-01 | CHLVPP | N | N | 250015945 | TRIAL |
| 250008134 | 250005593 | 1.7 | 81.9 | Curative (C) | 2018-12-16 | 2018-12-16 | Trial Unspecified | N | N | 250016044 | IMATINIB |
| 250008135 | 250005593 | 1.86 | 77.1 | Palliative (P) | 2017-06-29 | 2017-07-12 | HSV1716 | N | N | 250016044 | CYTARABINE |
| 250008136 | 250005594 | 1.66 | 60.5 | Palliative (P) | 2017-06-10 | 2017-06-10 | Pemetrexed | N | N | 250016148 | PILOT TRIAL |
| 250008137 | 250005595 | 1.69 | 68.8 | null | 2017-06-17 | 2017-08-21 | Trial Unspecified | N | N | 250016158 | LANREOTIDE |
| 250008138 | 250005595 | 1.58 | 72.6 | Curative (C) | 2015-03-17 | 2015-03-17 | Cisplatin + Paclitaxel | N | N | 250016158 | VINORELBINE |
| 250008139 | 250005595 | 1.57 | null | Neo-adjuvant (N) | 2018-04-18 | 2018-04-18 | Trial Unspecified | N | N | 250016158 | PEMETREXED |
| 250008140 | 250005596 | 1.57 | 81.9 | Palliative (P) | null | 2017-04-01 | IPM | null | N | 250016470 | TRIAL |
| 250008141 | 250005597 | 1.56 | 69.5 | Palliative (P) | 2017-04-19 | 2017-04-19 | Trial Unspecified | 2 | N | 250016567 | PEMETREXED |
| 250008142 | 250009929 | 1.72 | 0 | Curative (C) | 2015-04-25 | 2015-05-13 | Pemetrexed | N | N | 250016619 | CARBOPLATIN + ETOPOSIDE |
| 250008143 | 250009929 | 1.6 | 57.2 | Neo-adjuvant (N) | 2013-09-24 | 2014-03-18 | EC | null | N | 250016619 | CISPLATIN |
| 250008144 | 250009929 | 1.7 | 79 | Palliative (P) | 2015-09-12 | 2016-04-05 | Trial Unspecified | 2 | N | 250016619 | TRIAL |
| 250008145 | 250009929 | 1.72 | 140.9 | Palliative (P) | 2015-10-10 | 2015-10-11 | Pemetrexed | N | Y | 250016619 | FLAG |
| 250008146 | 250009929 | null | 67.6 | Adjuvant (A) | 2018-08-16 | 2018-08-16 | Trial Unspecified | 2 | N | 250016619 | CISPLATIN + PACLITAXEL |
| 250008147 | 250009929 | 1.56 | 61 | Disease modification (D) | 2016-08-04 | 2016-08-04 | Temozolomide 150mg/m2 | Y | N | 250016619 | TRIAL |
| 250008148 | 250005598 | 1.63 | 71 | Disease modification (D) | 2015-08-06 | 2015-08-08 | Pemetrexed | 2 | N | 250017200 | CYTARABINE |
| 250008149 | 250005599 | 1.78 | 86.6 | Palliative (P) | null | 2015-06-29 | MESO-02 TRIAL | N | N | 250017201 | GEMCARBO |
| 250008150 | 250009930 | 1.74 | 70 | Not known (9) | 2017-11-02 | 2017-11-02 | Vinorelbine (oral) | N | N | 250017208 | CISPLATIN |
| 250008151 | 250011688 | null | 54.9 | Disease modification (D) | null | 2017-01-31 | Carboplatin + Paclitaxel (3 weekly) | N | N | 250017259 | TRIAL |
| 250008152 | 250011688 | 1.72 | 70.3 | Disease modification (D) | 2015-03-25 | 2015-04-11 | ABVD | 02 | N | 250017259 | RUXOLITINIB |